October 17, 2026 01:41 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'How dare Elon Musk?' Owaisi defends Modi after billionaire's 'real boss' jibe at Ambani | 'B****y S***': IAS officer's abuse of female colleague during virtual J&K meeting sparks row | Aamir Khan’s nephew Imran Khan asked to leave India by Oct 28 after joining anti-CEC protest | ‘Their crime? Demanding justice’: Rahul Gandhi slams 4 AM detention of Ankita Bhandari’s parents | ‘Bangladesh showed us the way’: Neha Bora’s remarks spark BJP attack on Rahul Gandhi | Chingrighata flyover skid scare: Bikes fall, anti-skid blocks installed overnight as Bengal Minister Agnimitra Paul faces criticism | Meerut blue drum murder case: Muskaan, her lover get death sentence | 'Rise up, young patriots!': American singer Mary Millben alleges CJP gets US funding, urges peaceful protests | 'Won't go unchallenged': Muhammad Yunus heckling in New York triggers legal action warning | flydubai cockpit attack probe widens: Two Maldivian pilots detained in UAE over links to Omani co-pilot
Omicron
Unsplash

Omicron strain found in 63 countries, might surpass Delta in spreading speed: WHO

| @indiablooms | Dec 13, 2021, at 04:00 am

Geneva/UNI/Sputnik: The new Omicron coronavirus strain was found in 63 countries and, according to preliminary data, it will exceed Delta's spreading speed in the world, the World Health Organization (WHO) said.

"As of 9 December 2021, cases of human infections with this variant have been identified in 63 countries across all six WHO regions," the overview by the WHO read.

It is not clear yet, why the new strain is spreading so fast, the organization added.

"However, given the current available data, it is likely that Omicron will outpace the Delta variant where community transmission occurs," the document said.

The Omicron variant might reduce the effectiveness of COVID-19 vaccines based on preliminary data, but this strain is less dangerous than Delta, the organization assumed.

"There are limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for Omicron. Preliminary evidence, and the considerably altered antigenic profile of the Omicron spike protein, suggests a reduction in vaccine efficacy against infection and transmission associated with Omicron," the statement said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.